What are the Growth Drivers of Digital Genome Market ? Top Players - Life Technologies, Illumina, Thermo Fisher Scientific, and Roche
Increased adoption of personalized medicine aimed at identifying genomic markers of disease and prescribe drugs that specifically target the pathway will drive the digital genome market size. Growing emphasis on sensitivity and specificity of the gene sequencing instruments should also fuel industry growth.
In 2015, sequencing and analyzing instruments accounted for over 40% of digital genome market share. Technological innovation for development of novel instruments coupled with growing investments in genetic research will provide thrust to industry expansion. Sequencing chips should witness over 10% CAGR owing to continuous R&D in bioinformatics, microfluidics, enzymology, and nanotechnology providing innovative platforms for digital genome market growth.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1219
Biotechnology innovation has enabled development of genetically modified organisms (GMOs) in order to introduce specific improvements or traits. Successful production and commercialization of such modified organisms should stimulate business growth. Extensive applications in clinical diagnosis and research will also contribute to industry growth.
Effective disease management strategies for chronic ailments and growing number of private and public investments and grants are forecast to propel digital genome market growth over the forecast years.
Concerns pertaining to security and confidentiality of patient data, lack of experienced professional and complex return on investment structure may hamper the digital genome market growth. Increasing application of digital genomics in next generation sequencing and wide use of microbes in diagnostics industry will stimulate microbiology segment growth; the segment is anticipated to surpass USD 10 billion by 2024.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1219
Bio-pharmaceutical companies accounted for over 45% of digital genome market share due to increasing demand for targeted drug therapy. Growing usage trend for precision medicines should provide lucrative growth opportunities for segment growth.
U.S. digital genome market size accounted for over 80% of the North American revenue in 2015, mainly due to the presence of established healthcare infrastructure and advanced facilities for effective treatment and care. The successful completion of Human Genome Project (HGP) has attracted significant public and private initiatives, driving the business growth.
In 2015, Germany digital genome market size was valued at over USD 1.4 billion and is anticipated to witness considerable growth till 2024. Increasing investments by public and private companies for development of novel technologies should boost digital genome industry growth.
China digital genome market is set to witness over 10% CAGR owing to favorable government initiative for development of human genetic resources platform and increasing collaboration among research institutes for creation of genomic databases and biobanks.
Some of the players operating in this industry include Perkin Elmer, Qiagen, Illumina, Becton Dickinson, Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, Veracyte, Trovagene, Affymetrix and Neogen. The industry participants are investing heavily in R&D to develop innovative products which would provide competitive advantage.
Some of the major players in sequencing and analysis instruments market include Life Technologies, Illumina, Thermo Fisher Scientific, and Roche. Few of the advanced sequencing technologies are Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: proton/ PGM sequencing and SOLiD (sequencing by Oligonucleotide Ligation and Detection) sequencing.
Chapter 1. Methodology and Scope
1.1.1. Initial data exploration
1.1.2. Statistical model & forecast
1.1.3. Industry insights & validation
1.1.4. Scope, definitions & research assumptions
1.2. Data Sources
Chapter 2. Executive Summary
2.1. Digital Genome industry 3600 synopsis, 2012 – 2024 (USD Million)
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. End-use trends
2.1.5. Regional trends
Chapter 3. Digital Genome Industry Insights
3.1. Industry segmentation
3.2. Industry size and forecast, 2012 – 2024 (USD Million)
3.3. Industry impact forces
3.3.1. Growth drivers
220.127.116.11. Successful completion of the Human Genome Project
18.104.22.168. Increasing public-private investments, funds, and grants
22.214.171.124. Advances in biotechnology
126.96.36.199. Increased Application in clinical diagnosis
188.8.131.52. Rising use of personalized medicine
184.108.40.206. Rise in incidence and prevalence of chronic diseases
220.127.116.11. Reduced cost and high speed for DNA sequencing
3.3.2. Industry pitfalls & challenges
18.104.22.168. Unclear ROI of precision medicine
22.214.171.124. Lack of trained staff
3.4. Growth potential analysis
3.5. Porter's analysis
3.6. Technology landscape
3.6.1. Advent of novel technologies
3.7. Company market share analysis, 2015
3.7.1. Strategy dashboard
3.8. PESTEL analysis
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688
Blog : http://news-researchers.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What are the Growth Drivers of Digital Genome Market ? Top Players - Life Technologies, Illumina, Thermo Fisher Scientific, and Roche here
News-ID: 1692324 • Views: 382
More Releases from Global Market Insights, Inc.
Linear alpha olefins market size, share, trends, 2024, Key players are INEOS Oli …
The linear alpha olefins market report is a deep-dive collection of important deliverables. An inherent sub-vertical of the global chemical’s domain, the linear alpha olefins market has carved out quite a remunerative growth path in the recent years. The report enlists substantial details about this market with respect to its overall foothold in the chemical industry and how the product would find applications across major end-user sectors. Get sample copy of
N-hexyl alcohol market to hit USD 1.6 billion by 2024, key players are Sasol, Na …
Estimates claim that N-hexyl alcohol market valuation from food & beverage applications was worth USD 325 million in the year 2016 and is expected to register continuous growth during the estimated timeframe. Rising adoption of N-hexyl alcohol compounds as a flavoring agent for alcoholic beverages, fruits, and vegetables has bolstered product demand. Additionally, N-hexyl alcohol is utilized to develop additives for lubricants which are further used in food grain machine
Waterborne Coating Market: Global Industry Analysis, Growth, Trends and Forecast …
Global waterborne coating market is expected to expand at a considerable pace owing to high awareness of consumers towards the adoption of eco-friendly coatings. The product is considered a better choice for the environment and contains a less amount of solvent. Low toxicity due to less HAP emissions and VOC levels, alongside high water-content that helps in reducing air emissions, will augment the product demand over the forecast spell. Waterborne
Trend in automotive application to Asia Pacific expanded polyethylene foam marke …
Of late, expanded polyethylene foam has become a trendy petrochemical product in applications, ranging from automotive, construction, packaging, protective covers and sports goods. Eliminating cost of making expensive molds and offering tremendous cushion against vibrations, shocks and abrasion are some of the upsides that have encouraged emerging economies such as India, China, Vietnam and Malaysia to infuse funds in EPE for packaging goods, boost high thermal resistance and weight
More Releases for Genome
Digital Genome Market: Growing Funding for Genomics
Genomic sequencing technology is rapidly transitioning into clinical practice, and implementation of the same into healthcare systems has been supported by substantial government investment, accounting for ~US$ 4 billion in at least 14 countries. These national genomic-medicine initiatives are driving transformative change under real-life conditions while simultaneously addressing barriers to implement and gather evidence for broader adoption, thereby driving the market growth. The digital genome market was valued at US$ 11,065.31
Genome Editing Market - Assisting Global Expansion 2025
Global Genome Editing Market: Overview Also known as genome editing with engineered nucleases (GEEN), genome editing is a method of altering DNA within a cell in a safe manner. The technique is also used for removing, adding, or modifying DNA in the genome. By thus editing the genome, it is possible to change the primary characteristic features of an organism or a cell. Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2588
Genome Editing Market tremendous demand till 2025
Global Genome Editing Market: Overview Also known as genome editing with engineered nucleases (GEEN), genome editing is a method of altering DNA within a cell in a safe manner. The technique is also used for removing, adding, or modifying DNA in the genome. By thus editing the genome, it is possible to change the primary characteristic features of an organism or a cell. The global genome editing market can be
Genome Editing Market Growth Analysis by 2025
Genome editing is a technique in genetic engineering that involves inserting, deleting or replacing a DNA into the desired locations into a genome of the living organism to change the phenotype of the organism. Genome editing plays a very significant role in modern day biology and is widely used in biotechnology and biopharmaceutical industry to alter the genome of microorganisms to perform process like the fermentation which yield desired products
Genome Engineering Market - Global Industry Analysis 2025
Genome engineering is a process of insertion, deletion, modification or replacement of DNA bases in an organism. Genome engineering has exhibited potential benefits in gene therapy. For instance, various genetic disorders such as Hemophilia, Myotonic dystrophy, Alzheimer’s disease, Sickle cell anemia, Gaucher disease, Cystic fibrosis (involves correction of a single gene) or asthma, autoimmune diseases, cancer, diabetes, and heart disease (involves correction of multiple genes) can be treated using genomic
Genome Engineering Market Analysis & Key Trends 2023
“To develop innovative, technologically advanced and differentiated products, the leading companies are banking on agreements with laboratories and research institutes and pouring funds into ongoing research and development projects,” says the author of the report. The global genome engineering market is anticipated to reach a valuation of US$7.21 bn by 2023 from US$2.30 bn in 2015, expanding at a remarkable CAGR of 14.2% from 2015 to 2023. Increasing Funding by Biotechnology